Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125076395 | 12507639 | 5 | F | 201605 | 20160922 | 20160629 | 20160927 | EXP | PHHY2016MX088614 | NOVARTIS | 91.65 | YR | F | Y | 76.00000 | KG | 20160927 | MD | MX | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125076395 | 12507639 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 9.5 MG, QD, PATCH 10 (CM2) | 689220 | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | |||||
| 125076395 | 12507639 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 9.5 MG, PATCH 10 (CM2) 1 AND 1/4 PATCH | 22083 | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||||
| 125076395 | 12507639 | 3 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 9.5 MG, PATCH 10 (CM2) 1 AND 1/2 PATCH | 22083 | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||||
| 125076395 | 12507639 | 4 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 9.5 MG, QD PATCH 10 (CM2) | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 125076395 | 12507639 | 5 | SS | ONBREZ BREEZHALER | INDACATEROL | 1 | Respiratory (inhalation) | 150 UG, QD | 0 | 150 | UG | QD | |||||||
| 125076395 | 12507639 | 6 | C | EBIXA | MEMANTINE HYDROCHLORIDE | 1 | Oral | 10 MG, Q12H | 0 | 10 | MG | TABLET | Q12H | ||||||
| 125076395 | 12507639 | 7 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0.25 DF, (1/4 OF 95 MG) | 0 | .25 | DF | TABLET | |||||||
| 125076395 | 12507639 | 8 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 0.5 DF, (1/2 OF 25 MG) | 0 | .5 | DF | TABLET | |||||||
| 125076395 | 12507639 | 9 | C | BENTYL | DICYCLOMINE HYDROCHLORIDE | 1 | Unknown | 1 DF, Q12H | U | 0 | 1 | DF | Q12H | ||||||
| 125076395 | 12507639 | 10 | C | RANISEN | 2 | Unknown | D | 0 | |||||||||||
| 125076395 | 12507639 | 11 | C | TYLEX /00116401/ | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | 750 OT, QD AND THEN TO SUSPEND | U | 0 | QD | ||||||||
| 125076395 | 12507639 | 12 | C | QUETIAPINE. | QUETIAPINE | 1 | Oral | 0.5 DF (25 MG), QD | 0 | .5 | DF | TABLET | QD | ||||||
| 125076395 | 12507639 | 13 | C | MACRODANTIN | NITROFURANTOIN | 1 | Unknown | 1 DF, BID (1-0-1) | U | 0 | 1 | DF | BID | ||||||
| 125076395 | 12507639 | 14 | C | CRONOCAPS | 2 | Oral | 1 DF, QD | 0 | 1 | DF | CAPSULE | QD | |||||||
| 125076395 | 12507639 | 15 | C | MOTILIUM | DOMPERIDONE | 1 | Oral | 3 DF (10 MG), QD | 0 | 3 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125076395 | 12507639 | 1 | Senile dementia |
| 125076395 | 12507639 | 5 | Hypoxia |
| 125076395 | 12507639 | 6 | Senile dementia |
| 125076395 | 12507639 | 7 | Hypertension |
| 125076395 | 12507639 | 8 | Gastritis |
| 125076395 | 12507639 | 9 | Product used for unknown indication |
| 125076395 | 12507639 | 10 | Product used for unknown indication |
| 125076395 | 12507639 | 11 | Product used for unknown indication |
| 125076395 | 12507639 | 12 | Sleep disorder |
| 125076395 | 12507639 | 13 | Product used for unknown indication |
| 125076395 | 12507639 | 14 | Sleep disorder |
| 125076395 | 12507639 | 15 | Gastrointestinal motility disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125076395 | 12507639 | HO |
| 125076395 | 12507639 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125076395 | 12507639 | Drug intolerance | |
| 125076395 | 12507639 | Drug prescribing error | |
| 125076395 | 12507639 | Electrolyte imbalance | |
| 125076395 | 12507639 | Escherichia urinary tract infection | |
| 125076395 | 12507639 | Hypertension | |
| 125076395 | 12507639 | Incoherent | |
| 125076395 | 12507639 | Malaise | |
| 125076395 | 12507639 | Product use issue | |
| 125076395 | 12507639 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125076395 | 12507639 | 1 | 2013 | 20160614 | 0 | |
| 125076395 | 12507639 | 4 | 20160615 | 0 | ||
| 125076395 | 12507639 | 5 | 201312 | 0 | ||
| 125076395 | 12507639 | 6 | 201301 | 0 | ||
| 125076395 | 12507639 | 8 | 201606 | 0 | ||
| 125076395 | 12507639 | 12 | 201407 | 0 | ||
| 125076395 | 12507639 | 14 | 201607 | 0 | ||
| 125076395 | 12507639 | 15 | 201607 | 0 |